View of 29. Preliminary results of pembrolizumab monotherapy in recurrent or metastatic head and neck squamous cell carcinoma

Return to Article Details 29. Preliminary results of pembrolizumab monotherapy in recurrent or metastatic head and neck squamous cell carcinoma Download Download PDF